MedTrace Logo

Endovascular Repair of Thoracoabdominal Aortic Aneurysms

NCT04009512 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-12-14

No results posted yet for this study

Summary

The primary objective of this study is to assess the use of the thoracic bifurcation and the visceral manifold devices in the repair thoracoabdominal aortic aneurysms in patients with appropriate anatomy. The primary intent of the study is to assess safety and preliminary effectiveness of the device. Additionally, the study will assess technical success and treatment success at each follow-up interval.

Conditions

  • Thoracoabdominal Aortic Aneurysm

Interventions

DEVICE

Valiant Thoracoabdominal Stent Graft System

This system of devices works to facilitate endovascular stenting of the visceral vessels (renals, celiac, SMA) while maintaining flow to the visceral and infrarenal segments in patients with thoracoabdominal aneurysms.

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • NAMSA

    collaborator OTHER

  • Sanford Health

    collaborator OTHER

  • Matthew Eagleton

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-06
Primary Completion
2026-08-26
Completion
2026-08-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04009512 on ClinicalTrials.gov